Resource Logo
FDA News

Dronabinol (NDA 18651/SO11): Rescheduled from CII to CIII by Drug Enforcement Administration (DEA)




 

Food and Drug Administration - August 5, 1999

Trade Name: Marinol Generic Name: Dronabinol Packaging: 2.5 mg, 5 mg, and 10 mg capsules.

Sponsor: Unimed Pharmaceuticals Inc.

Provides for changes to the physician's package insert and patient's information insert per Unimed's petition to reschedule Marinol (Dronabinol) from CII to CIII according to the Drug Enforcement Administration (DEA).



 


Copyright © 1999 -FDA News, Publisher. All rights reserved to Food and Drug (FDA) Administration FDA.

Information in this article was accurate in August 5, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.